|
|
Toxicity and efficacy of combined radioimmunotherapy and bevacizumab in a mouse model of medullary thyroid carcinoma.
Pierre-Yves Salaun
,
Caroline Bodet-Milin
,
Eric Frampas
,
Aurore Oudoux
,
Catherine Saï-Maurel
,
et al.
Journal articles
hal-00930166v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Pretargeted radioimmunotherapy in rapidly progressing, metastatic, medullary thyroid cancer.
Françoise Kraeber-Bodéré
,
Pierre-Yves Salaun
,
Aurore Oudoux
,
David M Goldenberg
,
Jean-François Chatal
,
et al.
Journal articles
hal-00930004v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Prognostic value of interim FDG PET/CT in Hodgkin's lymphoma patients treated with interim response-adapted strategy: comparison of International Harmonization Project (IHP), Gallamini and London criteria.
Pierre-Yves Le Roux
,
Thomas Gastinne
,
Steven Le Gouill
,
Emmanuel Nowak
,
Caroline Bodet-Milin
,
et al.
Journal articles
istex
hal-00749883v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement.
Pierre-Yves Salaun
,
Loïc Campion
,
Claire Bournaud
,
Alain Faivre-Chauvet
,
Jean-Philippe Vuillez
,
et al.
Journal articles
hal-00932253v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Pharmacokinetics and Dosimetry Studies for Optimization of Pretargeted Radioimmunotherapy in CEA-Expressing Advanced Lung Cancer Patients.
Caroline Bodet-Milin
,
Ludovic Ferrer
,
Aurore Rauscher
,
Damien Masson
,
Latifa Rbah-Vidal
,
et al.
Journal articles
hal-01258870v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Pretargeted radioimmunotherapy (pRAIT) in medullary thyroid cancer (MTC).
Françoise Kraeber-Bodéré
,
Pierre-Yves Salaun
,
Catherine Ansquer
,
Delphine Drui
,
Eric Mirallié
,
et al.
Journal articles
hal-00932128v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?
Ronan Abgral
,
Solène Querellou
,
Gaël Potard
,
Pierre-Yves Le Roux
,
Alexandra Le Duc-Pennec
,
et al.
Journal articles
hal-00922914v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|